Home › Coronary Artery Disease › New Jersey
Coronary Artery Disease clinical trials in New Jersey
15 studies for Coronary Artery Disease are looking for participants at sites in New Jersey.
Cities in New Jersey
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Virtua Health, Camden
Recruiting
Ages 18 to 90 · All sexes · Updated Sep 30, 2026 · NCT07296744A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
- HACKENSACK MERIDIAN HEALTH, Inc, Jersey City
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 28, 2026 · NCT07286578Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Advanced Heart Care LLC, Bridgewater
- Cardiovascular Associates of the Delaware Valley, Elmer
- Advanced Heart and Vascular Institute Of Hunterdon, Flemington
- and 3 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565IVUS CHIP UPP Registry
- Barnabas Health, Jersey City
- Virtua Health, Marlton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06625801Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Product Surveillance Registry
- Camden
- Marlton
- Morristown
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
- Englewood Hospital, Englewood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06399705REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
- Englewood Hospital, Englewood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06399692Prevail Global Study
- Virtua Our Lady of Lourdes Hospital, Camden
- The Valley Hospital, Paramus
Recruiting
Ages 18 and older · All sexes · Updated Apr 24, 2026 · NCT06535854Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Englewood Health, Englewood
- Newark Beth Israel Medical Center, Newark
- The Valley Hospital, Ridgewood
Recruiting
Ages 18 and older · Women · Updated Apr 1, 2026 · NCT04124120MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- Atlanticare Regional Medical Center, Pomona
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 11, 2025 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Our Lady of Lourdes, Camden
- Valley Hospital, Ridgewood
Recruiting
All ages · All sexes · Updated Jul 24, 2025 · NCT04634240Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
- RWJ Barnabas Health, Jersey City
Recruiting
Ages 18 and older · All sexes · Updated Jun 19, 2025 · NCT05701358PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
- Deborah Heart and Lung Center, Browns Mills
Recruiting
Ages 18 to 90 · All sexes · Updated Jun 13, 2025 · NCT06445608MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- AtlantiCare Regional Medical Center, Pomona
Recruiting
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.